Literature DB >> 31322648

Chronic Binge Alcohol-Associated Differential Brain Region Modulation of Growth Factor Signaling Pathways and Neuroinflammation in Simian Immunodeficiency Virus-Infected Male Macaques.

John K Maxi1, Don Mercante2,3, Brittany Foret1, Sarah Oberhelman1, Tekeda F Ferguson2,3, Gregory J Bagby1,2, Steve Nelson2,4, Angela M Amedee2,5, Scott Edwards1,2, Liz Simon1,2, Patricia E Molina1,2.   

Abstract

AIMS: Microarray analysis of hippocampal tissue from chronic binge alcohol (CBA)-administered, simian immunodeficiency virus (SIV)-infected male macaques identified altered immune response and neurogenesis as potential mechanisms underlying cognitive deficits in macaques. This study investigated the differential brain region associations between markers of neuroinflammation and growth factor signaling with microtubule-associated protein 2 (MAP2) expression.
METHODS: Adult male rhesus macaques were administered CBA (13-14 g EtOH/kg/week, n = 8) or sucrose (SUC, n = 7) beginning 3 months prior to SIV infection and continued until animals reached end-stage disease criteria (3-24 months post infection). Expression of inflammatory cytokines, growth factors, and viral loads were determined in the prefrontal cortex (PFC), caudate (CD), and hippocampus (HP). Brain-derived neurotropic factor (BDNF) expression and phosphorylation of intracellular kinases downstream of BDNF were investigated in the PFC.
RESULTS: Our results show reduced MAP2 expression in the PFC of longer-surviving, CBA/SIV macaques. BDNF expression was most closely associated with MAP2 expression in the PFC. In the caudate, significant positive associations were observed between MAP2 and BDNF, time to end-stage and set-point viral load and significant negative associations for CBA. In the hippocampus, positive associations were observed between MAP2 and inflammatory cytokines, and negative associations for brain viral load and CBA.
CONCLUSIONS: CBA differentially affects growth factor and inflammatory cytokine expression and viral load across brain regions. In the PFC, suppression of growth factor signaling may be an important neuropathological mechanism, while inflammatory processes may play a more important role in the CD and HP.
© The Author(s) 2019. Medical Council on Alcohol and Oxford University Press. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31322648      PMCID: PMC6751413          DOI: 10.1093/alcalc/agz056

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  41 in total

Review 1.  Neurotrophin-regulated signalling pathways.

Authors:  Louis F Reichardt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

2.  Neuroinflammatory responses from microglia recovered from HIV-1-infected and seronegative subjects.

Authors:  Anuja Ghorpade; Yury Persidsky; Susan Swindells; Kathleen Borgmann; Raisa Persidsky; Spring Holter; Robin Cotter; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2005-06       Impact factor: 3.478

3.  Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation: pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex.

Authors:  K Rostasy; L Monti; C Yiannoutsos; M Kneissl; J Bell; T L Kemper; J C Hedreen; B A Navia
Journal:  Ann Neurol       Date:  1999-08       Impact factor: 10.422

4.  Basal ganglia metabolite abnormalities in minor motor disorders associated with human immunodeficiency virus type 1.

Authors:  H J von Giesen; H J Wittsack; F Wenserski; H Köller; H Hefter; G Arendt
Journal:  Arch Neurol       Date:  2001-08

5.  Cerebrospinal fluid markers that predict SIV CNS disease.

Authors:  J L Mankowski; S E Queen; J E Clements; M C Zink
Journal:  J Neuroimmunol       Date:  2004-12       Impact factor: 3.478

6.  Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain-derived neurotrophic factor in vivo: potential implication for neuronal cell death.

Authors:  Rachel L Nosheny; Alessia Bachis; Elio Acquas; Italo Mocchetti
Journal:  Eur J Neurosci       Date:  2004-12       Impact factor: 3.386

7.  Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment.

Authors:  David J Moore; Eliezer Masliah; Julie D Rippeth; Raul Gonzalez; Catherine L Carey; Mariana Cherner; Ronald J Ellis; Cristian L Achim; Thomas D Marcotte; Robert K Heaton; Igor Grant
Journal:  AIDS       Date:  2006-04-04       Impact factor: 4.177

8.  Selective neuronal vulnerability in HIV encephalitis.

Authors:  E Masliah; N Ge; C L Achim; L A Hansen; C A Wiley
Journal:  J Neuropathol Exp Neurol       Date:  1992-11       Impact factor: 3.685

9.  The effect of chronic binge ethanol consumption on the primary stage of SIV infection in rhesus macaques.

Authors:  Gregory J Bagby; David A Stoltz; Ping Zhang; Jay K Kolls; Julie Brown; Rudolf P Bohm; Richard Rockar; Jeanette Purcell; Michael Murphey-Corb; Steve Nelson
Journal:  Alcohol Clin Exp Res       Date:  2003-03       Impact factor: 3.455

10.  Alcohol unmasks simian immunodeficiency virus-induced cognitive impairments in rhesus monkeys.

Authors:  Peter J Winsauer; Joseph M Moerschbaecher; Ian N Brauner; Jeanette E Purcell; Jack R Lancaster; Gregory J Bagby; Steve Nelson
Journal:  Alcohol Clin Exp Res       Date:  2002-12       Impact factor: 3.455

View more
  2 in total

1.  Antiretroviral therapy administration reduces neuroinflammation without restoring brain-derived neurotrophic factor signaling in alcohol-administered simian immunodeficiency virus-infected macaques.

Authors:  John K Maxi; Brittany L Foret; Angela M Amedee; Lee S McDaniel; Steve Nelson; Liz Simon; Scott Edwards; Patricia E Molina
Journal:  AIDS       Date:  2021-07-15       Impact factor: 4.632

Review 2.  Pathophysiological Consequences of At-Risk Alcohol Use; Implications for Comorbidity Risk in Persons Living With Human Immunodeficiency Virus.

Authors:  Liz Simon; Scott Edwards; Patricia E Molina
Journal:  Front Physiol       Date:  2022-01-18       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.